Merit’s Embosphere Microspheres Receive Expanded Indication to Control Bleeding/Hemorrhaging in the Peripheral Vasculature

 

March 22, 2019—Merit Medical Systems, Inc. announced the FDA clearance of an expanded indication for its Embosphere microspheres for the embolization of blood vessels to occlude blood flow in the peripheral vasculature to control bleeding or hemorrhaging. It is the first spherical embolic device to be cleared for this use.

According to the company, Embosphere microspheres have now received more indications for use than any other spherical embolic on the market. With this approval, Embosphere microspheres are now indicated for use in embolization of arteriovenous malformations, hypervascular tumors, symptomatic uterine fibroids, prostatic arteries for the relief of symptoms related to benign prostatic hyperplasia, and for controlling bleeding/hemorrhaging in the peripheral vasculature.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.